本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

216.32
-1.7800-0.82%
盤後216.320.00000.00%17:21 EST
成交量:69.88萬
成交額:1.52億
市值:133.46億
市盈率:-47.66
高:221.80
開:217.85
低:213.02
收:218.10
52周最高:242.00
52周最低:124.06
股本:6,169.52萬
流通股本:6,008.34萬
量比:0.69
換手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-4.5384
每股收益(LYR):-6.7615
淨資產收益率:-818.43%
總資產收益率:-6.86%
市淨率:-69.04
市盈率(LYR):-31.99

資料載入中...

2026/02/11

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities